Home / SUNPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SUNPHARMA.NS make money? Does SUNPHARMA.NS have pricing power? What's the Earnings Whisper? Will SUNPHARMA.NS profit more as the business scales? What is SUNPHARMA.NS's management track record? Is SUNPHARMA.NS's current price justified?

Sun Pharmaceutical Industries Limited

₹1758.8 +$37.70 (+2.19%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1764

Day Range

₹1743.5₹1764.9

Year Range

₹1583.7₹2046.9

Market Cap

4.22T

AVG Volume

1.9M

Trailing/Forward PE

34.89/27.21

PEG ratio

4.61

Dividend Yield

0.91%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

SUNPHARMA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	584.62B
2025	525.78B
2024	484.97B
2023	438.86B
2022	386.54B
2021	334.98B
2020	328.38B
2019	290.66B
2018	264.16B
2017	313.23B

Net Income (INR) · A

SUNPHARMA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	114.79B
2025	109.29B
2024	95.76B
2023	84.74B
2022	32.73B
2021	29.04B
2020	37.65B
2019	26.41B
2018	21.62B
2017	69.64B

Operating Income (INR) · A

SUNPHARMA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	135.53B
2025	278.15B
2024	244.24B
2023	219.04B
2022	182.91B
2021	152.73B
2020	148.34B
2019	126.56B
2018	110.9B
2017	0

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Sun Pharmaceutical Industries Limited

Video analysis: SUNPHARMA.NS

News: SUNPHARMA.NS

Similar companies